PatientsLikeMe takes a holistic route to meet patient needs

February 28, 2017 Christoph Graener

Jamie Heywood, co-founder and chairman of PatientsLikeMe spoke to Mike Ward, Informa Pharma Intelligence’s insights global director of content, about the USD 100 million investment they received for the new partnership with iCarbonX to combine artificial intelligence, biology, genetics and patient data with the aim to fully digitize life and predict, prevent and treat diseases more effectively.

Interviewer: Mike Ward – Global Director of Content, Informa Pharma Insights
Interviewee: Jamie Heywood – Co-Founder and Chairman, PatientsLikeMe

Previous Article
Digital medicine will drive meaningful personalized clinical outcomes

Medidata president and co-founder Glen de Vries shares his views on how digital medicine has the potential ...

Next Article
Catabasis pursues bifunctional mutation-agnostic approach to DMD

Using its safely metabolized and rationally targeted (SMART) linker platform, Catabasis has identified an N...